Scavo Robert L.

Chief Information Officer Robert L. Scavo sold 69,541 shares of ALHC for $1,303,384.48 on 2025-12-29, reducing holdings by 12.1%.

Robert L. Scavo, Chief Information Officer at Alignment Healthcare, executed two separate sales on 2025-12-29, totaling 69,541 shares (69.5K shares) for $1,303,384.48 (blended average price $18.74), reducing his holdings from 572,555 shares to 503,014 shares (a 12.1% reduction). The transaction occurred near the 52-week high of $20.55, with the current price at $19.24. Notably, at the same ticker ALHC, Scavo's prior two sales on 2025-06-10 and 2025-06-11 showed negative 30-day returns (-8.4% and -12.0% respectively), indicating those earlier sales were preceded by near-term price weakness rather than strength. The company's fundamentals present a mixed picture: revenue reached $993,695,000.00 in the latest quarter with annual revenue growth of +48.2%, but the company reported net income of only $3,729,000.00 in the recent quarter and was unprofitable over its most recent full fiscal year, suggesting operational challenges despite topline growth. The scale of this reduction (nearly 12% of holdings) and the timing relative to the company's profitability headwinds warrant investor attention to whether this represents ordinary portfolio rebalancing or a broader executive confidence signal.

CIO Robert L. Scavo sells 100,863 shares for $1,497,255.50 at blended $14.84, reducing stake by 14.3%

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, executed 2 separate sales totaling 100,863 shares for $1,497,255.50 on June 10-11, 2025, reducing his holdings from 702,953 shares to 602,090 shares, representing a 14.3% reduction in his stake. The company is unprofitable with net income of $-9,114,000.00 on latest quarterly revenue of $926,932,000.00, though it shows strong annual revenue growth of +48.2% year-over-year. Scavo's prior sell at this ticker on 2025-03-06 returned -1.4% over 90 days, consistent with his cross-ticker pattern of well-timed selling (100.00% rate). The current stock price of $15.08 is -23.8% from the 52-week high of $19.78, placing the transaction prices ($14.60 and $15.20) below the recent high but near current levels.

CIO Robert L. Scavo sold 55,403 shares of ALHC at $15.53; retains 673,419 shares post-sale.

Scavo's sale of 55,403 shares at $15.53 represents a 7.6% reduction in his holdings and occurred near the stock's 52-week high of $15.81. The sale is modest in scale relative to his remaining position of 673,419 shares. Alignment Healthcare posted strong revenue growth of 48.2% year-over-year to $692.4M in the latest quarter, but the company remains unprofitable with a net loss of $26.4M, indicating margin pressures despite significant top-line expansion. The timing coincides with stock strength (the 90-day price change of +33.9% shows recent momentum), though this is a routine portfolio adjustment by a CIO maintaining substantial continued ownership.